Table 7.
Variable | Delayed GBS, N = 25 (8.5%) | No GBS, N = 268 (91.5%) | p Value |
---|---|---|---|
GERD-HRQL at 6 mo | |||
Total score, median (IQR) | 4 (2–9) | 4 (1–8) | 0.476 |
Heartburn item, median (IQR) | 0 (0–1) | 0 (0–0) | 0.156 |
Regurgitation item, median (IQR) | 0 (0–0) | 0 (0–1) | 0.617 |
Dysphagia item, median (IQR) | 0 (0–1) | 0 (0–2) | 0.407 |
Gas-bloat item, median (IQR) | 2 (1–3) | 1 (0–2) | 0.031 |
Freedom from PPI use | 84 | 94.6 | 0.062 |
Patient satisfaction | 91.7 | 93.6 | 0.664 |
GERD-HRQL at 1 y | |||
Total score, median (IQR) | 10 (5–25) | 4 (1–9) | <0.0001 |
Heartburn item, median (IQR) | 1 (0–2) | 0 (0–1) | 0.073 |
Regurgitation item, median (IQR) | 1 (0–1) | 0 (0–1) | 0.112 |
Dysphagia item, median (IQR) | 1 (0–1) | 0 (0–2) | 0.569 |
Gas-bloat item, median (IQR) | 4 (4–4) | 1 (0–2) | <0.0001 |
Freedom from PPI use, % | 86.4 | 94.4 | 0.149 |
Patient satisfaction, % | 79.2 | 92.8 | 0.037 |
Simethicone use, % | 40 | 23.9 | 0.073 |
pH normalization, % | 66.7 | 72.5 | 0.544 |
GBS, gas-bloat syndrome; GERD-HRQL, GERD health-related quality of life; IQR, interquartile range; PPI, proton pump inhibitor.